Hydroxychloroquine Sulphate is a synthetic 4-aminoquinoline pharmaceutical active pharmaceutical ingredient (API). It is the sulphate salt of hydroxychloroquine and is used in the manufacture of prescription medicines with antimalarial and immunomodulatory properties.
Hydroxychloroquine is used in pharmaceutical products approved for certain malaria infections and autoimmune conditions, including rheumatoid arthritis and systemic lupus erythematosus. Its pharmacological activity and suitability depend on the approved formulation and regulatory indication.
Hydroxychloroquine Sulphate API is intended for qualified pharmaceutical manufacturing. It should be supplied with an approved product specification, batch-specific Certificate of Analysis (COA) and appropriate quality documentation.
Hydroxychloroquine Sulphate is distinct from Hydroxychloroquine free base and Chloroquine Phosphate. These are different chemical substances and require separate product specifications and documentation.
Hydroxychloroquine is a 4-aminoquinoline compound. Its antimalarial activity is associated with its accumulation in parasite food vacuoles and interference with haemoglobin digestion and haem detoxification.
Its anti-inflammatory and immunomodulatory mechanisms are complex and are not fully established. These effects are associated with changes in intracellular processes, including lysosomal activity and immune signalling.
Hydroxychloroquine Sulphate is used as an API in the manufacture of approved pharmaceutical products, including:
The API is a pharmaceutical manufacturing raw material and is not itself a finished medicinal product.
The USP–NF monograph specifies that Hydroxychloroquine Sulphate contains not less than 98.0% and not more than 102.0% of C18H26ClN3O·H2SO4, calculated on the dried basis.
The European Pharmacopoeia monograph also specifies an assay range of 98.0–102.0%, calculated on the dried substance. The relevant pharmacopoeial analytical procedures and other acceptance criteria must be followed separately.
Quality control should include identification, assay, appearance of solution, related substances, water or loss on drying and other applicable tests. The current official monograph should be consulted for the precise analytical procedures and impurity limits.
The supplier should provide batch-specific analytical results and demonstrate compliance with the applicable pharmacopoeial and approved product specifications.
Hydroxychloroquine Sulphate should be packed in suitable, tightly closed pharmaceutical-grade containers that protect the material from contamination, moisture and light exposure.
The storage conditions, packaging configuration and retest period should be supported by the approved product specification and stability data. Follow the current applicable pharmacopoeial requirements and supplier recommendations.
Hydroxychloroquine Sulphate is a pharmacologically active prescription-drug substance. It should be handled by trained personnel using suitable personal protective equipment, appropriate containment and documented material-handling procedures.
Avoid unnecessary dust generation, inhalation and direct contact. Refer to the applicable safety data sheet for handling, storage and disposal requirements.
1. What is Hydroxychloroquine Sulphate?
It is the sulphate salt of hydroxychloroquine, a synthetic 4-aminoquinoline pharmaceutical compound.
2. What is the CAS number of Hydroxychloroquine Sulphate?
The CAS number is 747-36-4.
3. What is its molecular weight?
Its molecular weight is 433.95 g/mol.
4. What is the USP assay requirement?
The USP–NF monograph specifies 98.0–102.0%, calculated on the dried basis.
5. What is the difference between Hydroxychloroquine and Hydroxychloroquine Sulphate?
Hydroxychloroquine is the free base, while Hydroxychloroquine Sulphate is its sulphate salt. Their molecular weights and chemical specifications are different.
6. Is Hydroxychloroquine Sulphate the same as Chloroquine Phosphate?
No. Both belong to the 4-aminoquinoline family, but they are different active pharmaceutical ingredients.
7. What documentation should be requested from the supplier?
Request the current product specification, batch-specific COA, applicable pharmacopoeial compliance statement, impurity profile, residual-solvent information and stability documentation.
For technical and commercial enquiries regarding Hydroxychloroquine Sulphate API, request the current product specification, batch-specific COA, USP or Ph. Eur. compliance documentation, analytical method details and stability information from the supplier.
| Parameter | Specification |
|---|---|
| Appearance | White or practically white crystalline powder |
| Identification | IR and HPLC complaint |
| Assay (HPLC) | 98.0–102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.1% |
| Heavy Metals | NMT 10 ppm |
| Solubility | Freely soluble in water |